Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Davidson

Showing results (41-50 of 285) with videos related to

Pageof 29
Sort By:
Cancer Treatment and Research|July 14, 2009
Postoperative endocrine therapy for invasive breast cancerLeisha A Emens, Nancy E Davidson
Journal of Oncology Practice|May 11, 2017
Practical Approach to Triple-Negative Breast CancerVijayakrishna K Gadi, Nancy E Davidson
Cancer Cell|October 16, 2007
PI3 kinase activation and response to Trastuzumab Therapy: what's neu with herceptin resistance?Ben Ho Park, Nancy E Davidson
NEJM Evidence|July 23, 2024
TAILORing Estimates of Late Breast Cancer Recurrence with the RSClin ToolWilliam R Gwin, Nancy E Davidson
Lancet (London, England)|February 21, 2017
Optimal duration of trastuzumab for early HER2-positive breast cancerJennifer M Specht, Nancy E Davidson
Journal of the National Cancer Institute|September 26, 2025
RecOVARY? Using anti-Müllerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancerLynn K Symonds, Nancy E Davidson
The New England Journal of Medicine|June 28, 2002
Good news about oral contraceptivesNancy E Davidson, Kathy J Helzlsouer
The Oncologist|June 18, 2002
Preoperative therapy in breast cancer: lessons from the treatment of locally advanced diseaseAntonio C Wolff, Nancy E Davidson
The New England Journal of Medicine|June 7, 2011
"MAPping" the course of chemoprevention in breast cancerNancy E Davidson, Thomas W Kensler
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Adjuvant hormonal therapy for premenopausal women with breast cancerLeisha A Emens, Nancy E Davidson
Pageof 29

Showing results (41-50 of 285) with videos related to

Sort By:
Pageof 29
Cancer Treatment and Research|July 14, 2009
Postoperative endocrine therapy for invasive breast cancerLeisha A Emens, Nancy E Davidson
Journal of Oncology Practice|May 11, 2017
Practical Approach to Triple-Negative Breast CancerVijayakrishna K Gadi, Nancy E Davidson
Cancer Cell|October 16, 2007
PI3 kinase activation and response to Trastuzumab Therapy: what's neu with herceptin resistance?Ben Ho Park, Nancy E Davidson
NEJM Evidence|July 23, 2024
TAILORing Estimates of Late Breast Cancer Recurrence with the RSClin ToolWilliam R Gwin, Nancy E Davidson
Lancet (London, England)|February 21, 2017
Optimal duration of trastuzumab for early HER2-positive breast cancerJennifer M Specht, Nancy E Davidson
Journal of the National Cancer Institute|September 26, 2025
RecOVARY? Using anti-Müllerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancerLynn K Symonds, Nancy E Davidson
The New England Journal of Medicine|June 28, 2002
Good news about oral contraceptivesNancy E Davidson, Kathy J Helzlsouer
The Oncologist|June 18, 2002
Preoperative therapy in breast cancer: lessons from the treatment of locally advanced diseaseAntonio C Wolff, Nancy E Davidson
The New England Journal of Medicine|June 7, 2011
"MAPping" the course of chemoprevention in breast cancerNancy E Davidson, Thomas W Kensler
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Adjuvant hormonal therapy for premenopausal women with breast cancerLeisha A Emens, Nancy E Davidson
Pageof 29